Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
82.42
+0.90 (+1.10%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Jul 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
88
89
Next >
1 Dow Jones Stock to Target This Week and 2 to Avoid
Today 0:34 EDT
While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising costs, or disruptive new competitors.
Via
StockStory
Topics
Stocks
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults
July 15, 2025
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.
Via
Benzinga
Merck & Co Unusual Options Activity For July 15
July 15, 2025
Via
Benzinga
This House of Representative Just Bought Up To $30K In 3M Stock
July 15, 2025
Via
Benzinga
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
July 15, 2025
Via
Stocktwits
P/E Ratio Insights for Merck & Co
July 09, 2025
Via
Benzinga
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
July 14, 2025
BofA cuts Bristol Myers' 2025 EPS and sales estimates slightly and flags medium-term pressure from generics, while maintaining a Neutral rating.
Via
Benzinga
AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
July 14, 2025
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a favorable safety profile.
Via
Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
Via
Benzinga
Topics
Government
World Trade
MERCK & CO. INC. (NYSE:MRK) – A Strong Dividend Stock with Solid Fundamentals
July 11, 2025
MERCK & CO. (NYSE:MRK) offers a strong 4% dividend yield, consistent growth, and solid profitability, making it a top pick for income investors. The stock is also attractively valued.
Via
Chartmill
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
July 11, 2025
Via
The Motley Fool
Topics
Intellectual Property
Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps
July 09, 2025
Kazia's early trial data show significant CTC and cluster reduction in a breast cancer patient treated with Paxalisib, Keytruda, and chemotherapy.
Via
Benzinga
Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday?
July 09, 2025
Wall Street rose on Wednesday as investors shrugged off fresh trade uncertainty after the White House delayed the start of new tariffs to Aug. 1, raising hopes for new rounds of negotiations.
Via
Benzinga
Topics
World Trade
Explore the top gainers and losers within the S&P500 index in today's session.
July 09, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
July 09, 2025
Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.
Via
Benzinga
Topics
Intellectual Property
Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma
July 09, 2025
The takeover target just launched its first drug last summer. Shares have mostly trended higher since.
Via
Investor's Business Daily
Topics
Government
Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline
July 09, 2025
Merck will acquire Verona for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.
Via
Stocktwits
Topics
Government
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Merck (NYSE:MRK)
July 08, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Merck (NYSE:MRK) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
July 07, 2025
Via
The Motley Fool
Topics
Stocks
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report
July 04, 2025
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .
Via
Benzinga
Topics
Government
2 S&P 500 Stocks with Promising Prospects and 1 to Question
July 04, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...
Via
StockStory
Topics
Stocks
Uncover the latest developments among S&P500 stocks in today's session.
July 03, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via
Chartmill
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
July 03, 2025
Via
Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
July 03, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
July 03, 2025
Via
Benzinga
Merck's Hypertension Drug On FDA Fast Track For Label Expansion
July 02, 2025
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Via
Benzinga
MERCK & CO. INC. (NYSE:MRK) – A Strong Value Candidate in Healthcare
July 02, 2025
MERCK & CO. (NYSE:MRK) is an undervalued pharmaceutical stock with strong profitability, a healthy balance sheet, and a reliable dividend, making it a candidate for value investors.
Via
Chartmill
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
July 01, 2025
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields.
Via
Benzinga
Topics
Stocks
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?
July 01, 2025
The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.
Via
Benzinga
Topics
Stocks
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
July 01, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
88
89
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.